DexCom, Abbott to Benefit From Multi-billion-dollar OTC Continuous Glucose Market
Does DexCom (DXCM) Have a Long Runway For Growth?
It's No Surprise This Stock Had an Awful July. A Huge Tech Outage Can Do That.
BTIG Reaffirms Their Buy Rating on Dexcom (DXCM)
Express News | Dexcom Outlook FY Revenue USD 4,000-4,050 Million
Jim Cramer Says This Home Improvement Chain Is A Buy Ahead Of Fed Rate Cut Cycle: 'I Would Pick Some Up Tomorrow'
Top 3 Health Care Stocks That May Explode In Q3
DexCom Added to Raymond James Analyst Current Favorite List
Raymond James Maintains DexCom(DXCM.US) With Buy Rating, Cuts Target Price to $115
Redburn Atlantic Adjusts Price Target on DexCom to $80 From $130
DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?
Dexcom's Stock Downgrade: A Temporary Setback or a Buying Opportunity?
DexCom Options Spot-On: On July 29th, 68,305 Contracts Were Traded, With 164.54K Open Interest
Stocks Making the Biggest Moves Midday: Walt Disney, DexCom, McDonald's, On Semiconductor and More
DexCom Is Maintained at Equal-Weight by Barclays
DexCom Analyst Ratings
Tandem Diabetes Care, DexCom Say Health Canada Authorizes T:Slim X2 Insulin Pump
Behind the Scenes of DexCom's Latest Options Trends
Stocks on Sale: DexCom, Biogen, and L3Harris
Express News | Tandem Diabetes Care and Dexcom Announce the T:Slim X2 Insulin Pump With Dexcom G7 Cgm Compatibility Is Authorized for Sale by Health Canada
No Data